The Terrible Triad of Checkpoint Inhibition: A Case Report of Myasthenia Gravis, Myocarditis, and Myositis Induced by Cemiplimab in a Patient with Metastatic Cutaneous Squamous Cell Carcinoma

BACKGROUND: We report a case of a patient with squamous cell carcinoma (SCC) who developed myasthenia gravis (MG), myositis, and myocarditis after receiving cemiplimab, an anti-PD-1 immune checkpoint inhibitor (ICI). Case Presentation. An 86-year-old man with metastatic periocular SCC presented with...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Case Reports Immunol
Главные авторы: Jeyakumar, Nikeshan, Etchegaray, Mikel, Henry, Jason, Lelenwa, Laura, Zhao, Bihong, Segura, Ana, Buja, L. Maximilian
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi 2020
Предметы:
Case Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7355354/
https://ncbi.nlm.nih.gov/pubmed/32695533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/5126717
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы